510(k) Report

510(k) · Cleared

Cleared

Visucon-F Frozen Coag Screen N, Visucon-F Frozen Coag Screen Abn

K110432510(k) TraditionalCleared Oct 20, 2011247-day reviewClass II21 CFR 864.5425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Affinity Biologicals, Inc. · GGN Plasma, Coagulation Control

Cleared on Oct 20, 2011 as substantially equivalent to K082859 (Instrumentation Laboratory CO, 2008) after a 247-day review. Its family tree reaches back 3 generations to 2000.

Decided
Oct 20, 2011
Review
247 days
Class
Class II
Product code
GGN
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K002400 (2000). 11 ancestors in all, the oldest K864271 (1986). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2002: 2 other ancestors2000: 1 other ancestor1994: 2 other ancestors1993: 1 other ancestor1991: 1 other ancestor1986: 1 other ancestorK002400 · Modification of Acl Advance · Instrumentation Laboratory CO · 2000 · recalledK021023 · Hemosil Normal Control (Assayed); Hemosil Normal Control 1 (Unassayed) · Instrumentation Laboratory CO · 2002 · recalledK082859 · Hemosil Routine Control Level 1, Level 2, Level 3 Unassayed · Instrumentation Laboratory CO · 2008198519901995200020052010
  1. Root · 3 generations backK002400 Modification of Acl AdvanceInstrumentation Laboratory CO · 2000 · Recalled
  2. 2 generations backK021023 Hemosil Normal Control (Assayed); Hemosil Normal Control 1 (Unassayed)Instrumentation Laboratory CO · 2002 · Recalled
  3. 1 generation backK082859 Hemosil Routine Control Level 1, Level 2, Level 3 UnassayedInstrumentation Laboratory CO · 2008
  4. This deviceK110432 Visucon-F Frozen Coag Screen N, Visucon-F Frozen Coag Screen AbnAffinity Biologicals, Inc. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K002400Modification of Acl AdvanceInstrumentation Laboratory CO20002
−2K021023Hemosil Normal Control (Assayed); Hemosil Normal Control 1 (Unassayed)Instrumentation Laboratory CO20023
−1K082859Hemosil Routine Control Level 1, Level 2, Level 3 UnassayedInstrumentation Laboratory CO2008—
0 (this device)K110432Visucon-F Frozen Coag Screen N, Visucon-F Frozen Coag Screen AbnAffinity Biologicals, Inc.2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
199110
199310
199420
200010
200220
FIG. 1 — Lineage of K110432, 2000–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GGN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K082859Hemosil Routine Control Level 1, Level 2, Level 3 Unassayed
Summary page 1
…Subpart H, Hematology Kits and Packages Product Code: GGN Predicate Device: HemoslL Routine Control Level 1, K082859 Instrumentation Laboratory Device Description: The VisuCon-F Frozen Coag Screen INis a pool…
Instrumentation Laboratory CO2008—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 2 companies; a new generation was cleared every 2.8 years on median.
  • 4 of the 11 ancestors have a recall of any class.

How does its category compare?

All GGN devices

GGN Plasma, Coagulation Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · GGN

4in 2017

2007: 32008: 12009: 22010: 32011: 22012: 12013: 32014: 22016: 22017: 4
2007high 4 (2017) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GGN

96in 2017

2007: 47 days median2010: 23 days median2013: 441 days median2017: 96 days median
2007high 441 (2013) · low 23 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GGN

1in 2019

2010: 42011: 12013: 32019: 12026 (partial year): 2
2007high 4 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GGN

4in 2018

2009: 372010: 172011: 302012: 102013: 92014: 52015: 102016: 92017: 112018: 4
2007high 37 (2009) · low 0 (2007)2025

MAUDE reports naming product code GGN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200734700
20081—00
20092—037
2010323417
20112—130
20121—010
2013344139
20142—05
20150—010
20162—09
2017496011
20180—04
20190—10
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—2—

What is it indicated for?

The VisuCon-F Frozen Coag Screen N plasma is an assayed normal control plasma intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated partial thromboplastin time (APTI) and fibrinogen. in the normal range. The VisuCon-F Frozen Coag Screen N plasma may be used with mechanical and photo-optical coagulation instruments in conjunction with appropriate commercial reagents. The VisuCon-F Frozen…

Read the full statement (122 words)

The VisuCon-F Frozen Coag Screen N plasma is an assayed normal control plasma intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated partial thromboplastin time (APTI) and fibrinogen. in the normal range. The VisuCon-F Frozen Coag Screen N plasma may be used with mechanical and photo-optical coagulation instruments in conjunction with appropriate commercial reagents.

The VisuCon-F Frozen Coag Screen ABN plasma is an assayed abnormal control plasma intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated partial thromboplastin time (APTT), in the mid-level abnormal range. The VisuCon-F Frozen Coag Screen ABN plasma may be used with mechanical and photo-optical coagulation instruments in conjunction with appropriate commercial reagents.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K110432: Visucon-F Frozen Coag Screen N, Visucon-F Frozen Coag Screen Abn.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K110432

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026